BlackRock Fund Advisors’s Bellicum Pharmaceuticals, Inc. BLCM Stock Holding History

BlackRock Fund Advisors’s Portfolio BLCM Stock Details BLCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$14.4M	Buy	105,751 +11,229	+12%	+$1.99M	﹤0.01%	2367
2016 Q3	$18.8M	Buy	94,522 +6,202	+7%	+$1.07M	﹤0.01%	2101
2016 Q2	$11.4M	Buy	88,320 +32,539	+58%	+$3.62M	﹤0.01%	2326
2016 Q1	$5.22M	Buy	55,781 +2,252	+4%	+$245K	﹤0.01%	2723
2015 Q4	$10.8M	Buy	53,529 +31,375	+142%	+$5.61M	﹤0.01%	2400
2015 Q3	$3.22M	Buy	22,154 +65	+0.3%	+$11.9K	﹤0.01%	2992
2015 Q2	$4.7M	Sell	22,089 -1,311	-6%	-$321K	﹤0.01%	2960
2015 Q1	$5.42M	Buy	+23,400	New	+$5.66M	﹤0.01%	2803

Other funds holding BLCM

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

KCM

Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BlackRock Fund Advisors's BLCM Position: Q4 2016 in Review

BlackRock Fund Advisors increased its Bellicum Pharmaceuticals, Inc. (BLCM) stake by 12% in Q4 2016, buying an estimated $1.99M and bringing the position to 105,751 shares worth $14.4M. The position accounts for ﹤0.01% of the portfolio, ranked #2367.

BlackRock Fund Advisors first reported a position in BLCM in Q1 2015 and has held it in 8 quarters since. The position peaked at $18.8M in Q3 2016. 80 funds tracked by Wall St. Rank hold BLCM as of Q4 2016.

BlackRock Fund Advisors held 105,751 shares of Bellicum Pharmaceuticals, Inc. worth $14.4M as of Q4 2016.
BlackRock Fund Advisors bought 11,229 Bellicum Pharmaceuticals, Inc. shares in Q4 2016, an estimated $1.99M.
Bellicum Pharmaceuticals, Inc. made up ﹤0.01% of BlackRock Fund Advisors's portfolio in Q4 2016, its #2367 holding.
BlackRock Fund Advisors first reported a position in Bellicum Pharmaceuticals, Inc. in Q1 2015 and has held it in 8 quarters since.
BlackRock Fund Advisors's Bellicum Pharmaceuticals, Inc. position peaked at $18.8M in Q3 2016.
80 funds tracked by Wall St. Rank held Bellicum Pharmaceuticals, Inc. as of Q4 2016.

Based on BlackRock Fund Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.